Colgate-Palmolive (CL) is slated to report Q1 earnings on May 1, before the market opens. Wall Street forecasts EPS of $0.94, a 3.3% jump year-over-year, and revenue of $5.22 billion, up 6.3% from the same quarter in 2025. Investors are focused on organic sales growth and pricing power, especially in North America and emerging markets. Also, they will be closely watching gross margin trends, driven by easing commodity costs and ongoing productivity initiatives. Ahead of the results, CL stock is a Buy, according to the technical indicators, implying further upside from current levels.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Colgate-Palmolive is a global consumer products company known for its oral care, personal care, and household brands, led by its flagship Colgate toothpaste line.
Analyzing CL Stock’s Technical Indicators
According to TipRanks’ easy-to-understand technical analysis tool, Colgate-Palmolive stock is currently on an upward trend. Williams %R helps traders see if a stock is overbought or oversold. For CL stock, Williams %R currently shows a Buy signal, suggesting the stock is not overbought and has room to run.
Moreover, the Rate of Change (ROC) is a momentum-based technical indicator. It measures the percentage change in a stock’s price between the current price and the price from a specific number of periods ago. Typically, an ROC above zero confirms an uptrend. Colgate-Palmolive currently has an ROC of 1.8%, which signals a Buy.
Is CL Stock a Buy or Sell?
Turning to Wall Street, analysts have a Moderate Buy consensus rating on Colgate-Palmolive stock based on 11 Buys and five Holds assigned in the last three months. Further, the average CL price target of $94.58 per share implies 12.23% upside potential.
